Aller au contenu

The Science of Parkinson's

@scienceofpd.bsky.social did:plc:e4rz3xlsverunfboboqdap7i

Personal account of the Director of Research at Cure Parkinson's - All views my own - Kiwi - Kia kaha - 侘寂 - https://scienceofparkinsons.com/

Sur Bluesky depuis le

Abonnés
857
Abonnements
8
Posts
3 055
Jours dans les classements
0

Résumé

The Science of Parkinson's (@scienceofpd.bsky.social) est sur Bluesky depuis le 12 novembre 2024. Le compte a 857 abonnés, suit 8 comptes et a publié 3 055 posts.

Présence dans les classements

Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.

Ce compte n’est encore apparu dans aucun classement quotidien.

Posts aimés récemment

J’aime publics du réseau Bluesky.

  • Cure Parkinson's@cureparkinsons.org.uk

    Less than 5% of people with Parkinson’s are taking part in clinical research studies. Let’s change that. We’re calling on MPs to pledge their support and declare “I support Cure Parkinson’s campaign to empower more people living with Parkinson’s to take part in research.” Join us: buff.ly/UwhLmz7

    Voir le post
  • Cure Parkinson's@cureparkinsons.org.uk

    On Monday 16 November, Cure Parkinson's and France Parkinson are hosting an in-person and online public conference exploring how platform trials could accelerate the search for treatments that slow, stop or reverse Parkinson's. Book your place: buff.ly/W8gMg91

    Voir le post
  • Cure Parkinson's@cureparkinsons.org.uk

    We are excited to announce that we have committed £1.4 million to several new projects focused on testing combination therapies for Parkinson’s. These involve a range of potentially disease-modifying treatments, targeting different aspects of Parkinson’s progression. Read more: buff.ly/ZDRBOOv

    Voir le post
  • Cure Parkinson's@cureparkinsons.org.uk

    Results from Exenatide-PD3 sub-study, funded by Cure Parkinson’s, reveal a new way to predict Parkinson’s progression. Exenatide-PD3 was a phase 3 clinical trial of the Type 2 diabetes drug exenatide (Bydureon) which finished in early 2024. Find out more about the study: buff.ly/AjR8rjO

    Voir le post
  • Cure Parkinson's@cureparkinsons.org.uk

    Missed our Parkinson’s and dementia webinar? You can now catch up with the recording, featuring Edinburgh University’s Professor Tilo Kunath and an expert panel discussing the relationship between Parkinson’s and dementia. Watch now: buff.ly/0G5VXkR

    Voir le post

Connectez-vous pour en voir plus

Comptes bloqués

Sur Bluesky, les blocages sont publics.

Ce compte ne bloque personne.